ACM
ABEO icon

ADAR1 Capital Management’s Abeona Therapeutics ABEO Stock Holding History

ADAR1 Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,322
Closed -$154K – 215
2024
Q3 		$154K Sell
24,322
-88,803
-78% -$464K 0.03% 173
2024
Q2 		$480K Buy
+113,125
New +$577K 0.09% 103

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ADAR1 Capital Management's ABEO Position: Q4 2024 in Review

ADAR1 Capital Management sold out of Abeona Therapeutics (ABEO) in Q4 2024, closing a stake of 24,322 shares — an estimated $154K sold.

ADAR1 Capital Management first reported a position in ABEO in Q2 2024 and held it in 2 quarters. The position peaked at $480K in Q2 2024. 65 funds tracked by Wall St. Rank hold ABEO as of Q4 2024.

  • ADAR1 Capital Management reported no remaining Abeona Therapeutics position as of Q4 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 24,322 Abeona Therapeutics shares in Q4 2024, an estimated $154K.
  • ADAR1 Capital Management first reported a position in Abeona Therapeutics in Q2 2024 and held it in 2 quarters.
  • ADAR1 Capital Management's Abeona Therapeutics position peaked at $480K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2024.

Based on ADAR1 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.